Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb 19:9:3187.
doi: 10.3389/fimmu.2018.03187. eCollection 2018.

Human Immune Responses and the Natural History of Neisseria gonorrhoeae Infection

Affiliations
Review

Human Immune Responses and the Natural History of Neisseria gonorrhoeae Infection

Angela Lovett et al. Front Immunol. .

Abstract

The intimate relationship between humans and Neisseria gonorrhoeae infections span centuries, which is evidenced in case reports from studies dating back to the late 1700s and historical references that predate medical literature. N. gonorrhoeae is an exclusive human pathogen that infects the genital tract of both men and women as well as other mucosal surfaces including the oropharynx and rectum. In symptomatic infections, N. gonorrhoeae induces a robust inflammatory response at the site of infection. However, infections can also present asymptomatically complicating efforts to reduce transmission. N. gonorrhoeae infections have been effectively treated with antibiotics since their use was introduced in humans. Despite the existence of effective antibiotic treatments, N. gonorrhoeae remains one of the most common sexually transmitted pathogens and antibiotic resistant strains have arisen that limit treatment options. Development of a vaccine to prevent infection is considered a critical element of controlling this pathogen. The efforts to generate an effective gonococcal vaccine is limited by our poor understanding of the natural immunologic responses to infection. It is largely accepted that natural protective immunity to N. gonorrhoeae infections in humans does not occur or is very rare. Previous studies of the natural history of infection as well as some of the humoral and cellular immune responses to infection offer a window into the issues surrounding N. gonorrhoeae vaccine development. In this review, we summarize the current body of knowledge pertaining to human immune responses to gonococcal infections and the role of these responses in mediating protection from N. gonorrhoeae.

Keywords: Neisseria gonorrhoeae; human infection; immune response; immunoglobulin; lymphocyte; natural history.

PubMed Disclaimer

Figures

Figure 1
Figure 1
N. gonorrhoeae exposure can lead to bacterial clearance or prolonged infection with or without symptoms. A diagram of the natural history of N. gonorrhoeae infection after exposure demonstrates as many as 33% of exposed individuals will not develop infection. Infected individuals can have symptoms or remain asymptomatic. Asymptomatic infection can eventually progress to symptomatic infection, with studies indicating this progression may occur in as many as 25% of asymptomatic infections. Symptomatic infection can persist at least 14 days and infection is documented to last as long as 1 year. Asymptomatic infection is documented to persist as long as 165 days with as many as 25% of asymptomatic infections clearing over that time frame. The use of antibiotic therapy in all studies generating these data limit our knowledge of the actual rates of bacterial clearance and length of time chronic infection can persist.

References

    1. Schofield CB. Some factors affecting the incubation period and duration of symptoms of urethritis in men. Br J Vener Dis. (1982) 58:184–7. 10.1136/sti.58.3.184 - DOI - PMC - PubMed
    1. Sherrard J, Barlow D. Gonorrhoea in men: clinical and diagnostic aspects. Genitourin Med. (1996) 72:422–6. 10.1136/sti.72.6.422 - DOI - PMC - PubMed
    1. Svindland HB, Svarva PL, Maeland JA. Quinolone derivative, flumequine, as short-term treatment for gonorrhoea. Br J Vener Dis. (1982) 58:317–20. 10.1136/sti.58.5.317 - DOI - PMC - PubMed
    1. Hook EW, III, Olsen DA, Buchanan TM. Analysis of the antigen specificity of the human serum immunoglobulin G immune response to complicated gonococcal infection. Infect Immun. (1984) 43: 706–9. - PMC - PubMed
    1. Tanphaichitra D, Sahaphong S, Srimuang S. Ofloxacin, a new quinolone in the treatment of genitourinary and enteric infections. Infection (1986) 14 (Suppl. 4):S321–3. 10.1007/BF01661308 - DOI - PubMed

Publication types